pCI-Neo-gp78 R2M / JM21 Citations (3)

Originally described in: The tumor autocrine motility factor receptor, gp78, is a ubiquitin protein ligase implicated in degradation from the endoplasmic reticulum.
Fang S, Ferrone M, Yang C, Jensen JP, Tiwari S, Weissman AM Proc Natl Acad Sci U S A. 2001 Dec 4. 98(25):14422-7. PubMed Journal

---

Articles Citing pCI-Neo-gp78 R2M / JM21

Articles
Optimization of the Gal4-UAS system in an Anopheles gambiae cell line. Lynd A, Lycett GJ. Insect Mol Biol. 2011 Oct;20(5):599-608. doi: 10.1111/j.1365-2583.2011.01090.x. Epub 2011 Jun 24. PubMed
De-acetylation and degradation of HSPA5 is critical for E1A metastasis suppression in breast cancer cells. Chang YW, Chen HA, Tseng CF, Hong CC, Ma JT, Hung MC, Wu CH, Huang MT, Su JL. Oncotarget. 2014 Nov 15;5(21):10558-70. PubMed
Deacetylation of HSPA5 by HDAC6 leads to GP78-mediated HSPA5 ubiquitination at K447 and suppresses metastasis of breast cancer. Chang YW, Tseng CF, Wang MY, Chang WC, Lee CC, Chen LT, Hung MC, Su JL. Oncogene. 2015 Jun 29. doi: 10.1038/onc.2015.214. PubMed

If you have published an article using this material, please email us at to have your article added to this page.